Validated using a knockout cell line
Recombinant
RabMAb

Anti-MGMT antibody [EPR4397] (ab108630)

Publishing research using ab108630? Please let us know so that we can cite the reference in this datasheet.

ab108630 has been referenced in 2 publications.

  • Lai SW  et al. Differential Characterization of Temozolomide-Resistant Human Glioma Cells. Int J Mol Sci 19:N/A (2018). PubMed: 29301329
  • Niittykoski M  et al. Immunohistochemical Characterization and Sensitivity to Human Adenovirus Serotypes 3, 5, and 11p of New Cell Lines Derived from Human Diffuse Grade II to IV Gliomas. Transl Oncol 10:772-779 (2017). PubMed: 28797937

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up